RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS FROM THE GERMAN CHRONIC KIDNEY DISEASE STUDY

Schneider M, Meiselbach H, Schulmann T, Cornea G, Eckardt KU (2019)

Publication Type: Conference contribution

Publication year: 2019

Journal

Nephrology Dialysis Transplantation Oxford University Press (OUP): Policy B

Publisher: OXFORD UNIV PRESS

City/Town: OXFORD

Conference Proceedings Title: NEPHROLOGY DIALYSIS TRANSPLANTATION

Event location: Budapest HU

DOI: 10.1093/ndt/gfz106.fp417

Authors with CRIS profile

Markus Schneider Medizinische Fakultät Kai-Uwe Eckardt Department of Medicine 4 – Nephrology and Hypertension

Involved external institutions

Vifor Pharma AG CH Switzerland (CH)

How to cite

APA:

Schneider, M., Meiselbach, H., Schulmann, T., Cornea, G., & Eckardt, K.-U. (2019). RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS FROM THE GERMAN CHRONIC KIDNEY DISEASE STUDY. In NEPHROLOGY DIALYSIS TRANSPLANTATION. Budapest, HU: OXFORD: OXFORD UNIV PRESS.

MLA:

Schneider, Markus, et al. "RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE: AN ANALYSIS FROM THE GERMAN CHRONIC KIDNEY DISEASE STUDY." Proceedings of the 56th Congress of the European-Renal-Association (ERA)-European-Dialysis-and-Transplant-Association (EDTA) - Burden, Access and Disparities in Kidney Disease, Budapest OXFORD: OXFORD UNIV PRESS, 2019.

BibTeX: Download